HPE
72
-6
LLY
62
-6
NAVI
52
2
VFC
36
2
MAC
64
4
EXPE
53
-3
C
55
-3
MAT
37
-6
VIX
35
2
PSA
43
2
SJM
36
-2
STX
56
-3
KSS
51
2
GPS
59
4
STI
5
-2
WYNN
40
2
SYK
48
-2
TROW
40
3
MCD
38
2
CMI
58
8
HPE
72
-6
LLY
62
-6
NAVI
52
2
VFC
36
2
MAC
64
4
EXPE
53
-3
C
55
-3
MAT
37
-6
VIX
35
2
PSA
43
2
SJM
36
-2
STX
56
-3
KSS
51
2
GPS
59
4
STI
5
-2
WYNN
40
2
SYK
48
-2
TROW
40
3
MCD
38
2
CMI
58
8
Financhill
Back

Altimmune Stock Predictions

Free 23-page book shares my #1 indicator to use

Here's the 23-page free book.
Sell
44

ALT
Altimmune

Last Price:
6.62
Seasonality Move:
-2.76%

7 Day Trial

ALL ACCESS PASS

$ 7

This New Idea is Set to Shock the World

Click here to learn all the details.

Altimmune Stock Forecast

  • Over the next 52 weeks, Altimmune has on average historically risen by 5.9% based on the past 18 years of stock performance.
  • Altimmune has risen higher in 7 of those 18 years over the subsequent 52-week period, corresponding to a historical accuracy of 38.89%
  • Is Altimmune Stock Undervalued?
    The current Altimmune [ALT] share price is $6.60. The Score for ALT is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • ALT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Altimmune Stock Go Up Next Year?

  • Over the next 52 weeks, Altimmune has on average historically risen by 5.9% based on the past 18 years of stock performance.

Altimmune Stock Rating

Sell
44
Altimmune (ALT) is a Sell

Is Altimmune overpriced?

  • Altimmune has risen higher in 7 of those 18 years over the subsequent 52-week period, corresponding to a historical accuracy of 38.89%

Altimmune Stock Price History

Is ALT stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALT is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
altimmune.com

52-Week Data

52-Week High:
14.84
52-Week Low:
2.09

Prediction Charts

Market Cap:
469.37M
Price in USD:
6.60
Volume:
1.91M
Beta:
1.16

Technical Analysis

SMA50:
7.07
SMA100:
8.26
SMA200:
6.97
52-Wk Change:
91.3%

Stock Predictions

  • Is Altimmune stock public?
    Yes, Altimmune is a publicly traded company.
  • What is the Altimmune stock quote today?
    The Altimmune stock price is 6.60 USD today.
  • How to buy Altimmune stock online?
    You can buy Altimmune shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jun-13 6.39 6.61 6.68 6.27
Jun-14 6.49 6.11 6.54 6.09
Jun-17 6.11 5.92 6.11 5.83
Jun-18 5.93 5.91 5.93 5.64
Jun-20 5.90 5.94 6.08 5.78
Jun-21 6.00 6.40 6.76 5.99
Jun-24 7.47 7.14 8.49 7.08
Jun-25 7.11 7.41 7.53 6.61
Jun-26 7.25 6.26 7.34 6.22
Jun-27 6.33 6.39 6.90 6.06
Jun-28 6.39 6.65 6.67 6.30
Jul-1 6.67 7.20 7.31 6.66
Jul-2 7.10 6.74 7.47 6.71
Jul-3 6.77 6.60 7.00 6.52

Altimmune Earnings

Altimmune Earnings Report: Per Share Altimmune Earnings Q1 Q2 Q3 and Q4 last year and next year.

Altimmune Forecast Revenue Growth

Altimmune Stock Analysis: Historical quarterly revenues per share for Altimmune and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.63 per share, a decrease next quarter of $0.54 per share, an increase this year of $0.64 per share, and a decrease next year of $0.73 per share.

* Altimmune stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.